Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 32-36

  Kashiwakura, Jun Ichi ^a   Yanagisawa, Masahiko ^a,b   Lee, Hyunho ^a,b   Okamura, Yuki ^a,b   Sasaki Sakamoto, Tomomi ^a   Saito, Shu ^b   Tokuhashi, Yasuaki ^b   Ra, Chisei ^a   Okayama, Yoshimichi ^a  

^a Department of Molecular Cell Immunology and Allergology ^*  (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immune complex; Interleukin 33; Mast cells; Rheumatoid arthritis; Tumor necrosis factor alpha

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN G; INTERLEUKIN 33; INTERLEUKIN 8; PROTEIN; ST2 PROTEIN; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; FC RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANTIGEN ANTIBODY COMPLEX; CELL ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN AGGREGATE; IMMUNOHISTOCHEMISTRY; MAST CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION; ARTICLE; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; METABOLISM; SYNOVIUM;

ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; HUMANS; INTERLEUKIN-8; INTERLEUKINS; MAST CELLS; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84880542561     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350424     Document Type: Conference Paper

References (19)

1. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G: Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009; 284:19420-19426.
2. Hong YS, Moon SJ, Joo YB, Jeon CH, Cho ML, Ju JH, Oh HJ, Heo YJ, Park SH, Kim HY, Min JK: Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011; 26:1132-1139.
3. Xu D, Jiang HR, Li Y, Pushparaj PN, Kurow-ska-Stolarska M, Leung BP, Mu R, Tay HK, McKenzie AN, McInnes IB, Melendez AJ, Liew FY: IL-33 exacerbates autoantibody-in-duced arthritis. J Immunol 2010; 184:2620-2626.
4. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C: Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009; 60: 738-749.
5. Kunisch E, Chakilam S, Gandesiri M, Kinne RW: IL-33 regulates TNF-α dependent effects in synovial fibroblasts. Int J Mol Med 2012; 29: 530-540.
6. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297:1689-1692.
7. Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, Kawakami T, Karin M, Corr M: JNK1 controls mast cell degranu-lation and IL-1β production in inflammatory arthritis. Proc Natl Acad Sci USA 2010; 107: 22122-22127.
8. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thor-leifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H, Williams C, Hui J, Beilby J, Warrington NM, James A, Palmer LJ, Kop-pelman GH, Heinzmann A, Krueger M, Boezen HM, Wheatley A, Altmuller J, Shin HD, Uh ST, Cheong HS, Jonsdottir B, Gisla-son D, Park CS, Rasmussen LM, Porsbjerg C, Hansen JW, Backer V, Werge T, Janson C, Jonsson UB, Ng MC, Chan J, So WY, Ma R, Shah SH, Granger CB, Quyyumi AA, Levey AI, Vaccarino V, Reilly MP, Rader DJ, Williams MJ, van Rij AM, Jones GT, Trabetti E, Malerba G, Pignatti PF, Boner A, Pescollde-rungg L, Girelli D, Olivieri O, Martinelli N, Ludviksson BR, Ludviksdottir D, Eyjolfsson GI, Arnar D, Thorgeirsson G, Deichmann K, Thompson PJ, Wjst M, Hall IP, Postma DS, Gislason T, Gulcher J, Kong A, Jonsdottir I, Thorsteinsdottir U, Stefansson K: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41:342-347.
9. Malone DG, Irani AM, Schwartz LB, Barrett KE, Metcalfe DD: Mast cell numbers and his-tamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986; 29:956-963.
10. Tetlow LC, Woolley DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995; 54:896-903.
11. Eklund KK: Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007; 217:38-52.
12. Nigrovic PA, Lee DM: Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007; 217:19-37.
13. Sawamukai N, Yukawa S, Saito K, Nakayama-da S, Kambayashi T, Tanaka Y: Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-me-diated signaling. Arthritis Rheum 2010; 62: 952-959.
14. Ho LH, Ohno T, Oboki K, Kajiwara N, Suto H, Iikura M, Okayama Y, Akira S, Saito H, Galli SJ, Nakae S: IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals. J Leukoc Biol 2007; 82: 1481-1490.
15. Lee H, Kashiwakura J, Matsuda A, Watanabe Y, Sakamoto-Sasaki T, Matsumoto K, Hashimoto N, Saito S, Ohmori K, Nagaoka M, Tokuhashi Y, Ra C, Okayama Y: Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through FcγRI and FcγRII. Arthritis Rheum 2012; 65:109-119.
16. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
17. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fix-man ED, Hamid QA, Herszberg B, Lavoie JP, McVicker CG, Moir LM, Nguyen TT, Peng Q, Ramos-Barbon D, Stewart AG: Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004; 114:S2-S17.
18. Okayama Y, Hagaman DD, Metcalfe DD: A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of FcγRI or FcεRI. J Immunol 2001; 166:4705-4712.
19. Kobayashi R, Okamura S, Ohno T, Saito H, Mori M, Ra C, Okayama Y: Hyperexpression of FcγRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients. Clin Immunol 2007; 125:149-158.